Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
Tickers ALT JNJ LLY NVO
Tags Large Cap PFE Biotech
From Benzinga
While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer
Tickers ALT MYNZ PFE RHHBY
Tags General Market News ALT
From Benzinga
Roche's Combination Therapy Shows Improved Progression Free Survival In Certain Breast Cancer With Mutation
Tickers RHHBF RHHBY RHHVF
Tags General RHHVF Benzinga
From Benzinga
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
Tickers LLY NVO RHHBY
Tags Carmot Therapeutics Roche Holding Ozempic
From Benzinga
Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs
Tickers LLY NVO RHHBF RHHBY
Tags LLY Biotech Benzinga
From Benzinga
AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: Report
Tickers ABSI AZN NVDA RHHBY
Tags Briefs General ABSI
From Benzinga
Ignore Crypto: These Stocks Could Make You Rich
Tickers MDT NEE RHHBY
Tags Market News Recent Press Releases MDT
From Motley Fool
Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare
Tickers CLDX LUNG PSTX RHHBY
Tags CLDX RHHBY PSTX
From InvestorPlace
FDA Approves Bristol-Myers' Lung Cancer Drug Acquired Via $4B Turning Point Deal: Competes With Roche, Merck, AstraZeneca
Tickers AZN BMY MRK RHHBY
Tags Benzinga Markets AZN
From Benzinga
The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?
Tickers BIIB LLY RHHBY
Tags LLY Market News BIIB
From Motley Fool
Regeneron's Skin Drugs Propel Revenue In Q3, Witnesses Strong Demand For Higher Dose Version Of Flagship Eye Drug
Tickers REGN RHHBY
Tags Large Cap Benzinga Biotech
From Benzinga
Sarepta/Roche's Closely Watched Duchenne Gene Therapy Faces More FDA Scrutiny - Stock Tanks
Tickers RHHBF RHHBY RHHVF SRPT
Tags RHHBY Health Care News
From Benzinga
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
Tickers BHC CAH CVS NVS
Tags Health Care RHHBY News
From Benzinga
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
Tickers LLY PFE RHHBY
Tags RHHBY PFE Recent Press Releases
From Motley Fool
It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy
Tickers PFE RHHBY ROIV XBI
Tags Market News ROIV XBI
From Motley Fool
Why Is Roivant Sciences (ROIV) Stock Up Today?
Tickers PFE RHHBY ROIV
Tags Today's Market RHHBY PFE
From InvestorPlace
Roche Buys Pfizer & Roivant Sciences' Televant In ~$7.1B Deal
Tickers PFE RHHBF RHHBY ROIV
Tags Large Cap PFE Equities
From Benzinga
Roivant, Pfizer shares rise as Roche agrees to buy immunology company for $7.1 billion
Tickers PFE RHHBY ROIV
Tags RHHBY PFE ROIV
From MarketWatch
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
Tickers BMY BNTX PFE REGN
Tags BMY Market News RHHBY
From Motley Fool
PTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion
Tickers PTCT RHHBY RPRX SPX
Tags RPRX SPX PTCT
From MarketWatch
Roche Reports Nine Months Sales Growth Despite Lower Sales From COVID-19 Products
Tickers RHHBF RHHBY RHHVF
Tags RHHBY Health Care News
From Benzinga
What's Going On Cancer Player Monte Rosa Therapeutics Stock Today?
Tickers GLUE RHHBF RHHBY RHHVF
Tags Biotech Benzinga GLUE
From Benzinga
FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication
Tickers AZN BMY MRK RHHBY
Tags General Briefs News
From Benzinga
Why Is Alzheimer's Player Prothena Stock Trading Higher Today?
Tickers BMY NVO PRTA RHHBY
Tags Market News Rumors M&A
From Benzinga
Tempest Therapeutics shares head back to earth after 4,000% gain
Tickers RHHBY SPX TPST
Tags RHHBY SPX TPST
From MarketWatch
TPST Stock: 7 Things to Know About Tempest Therapeutics
Tickers RHHBY TPST
Tags NASDAQ:TPST,OTCMKTS:RHHBY Market News TPST
From InvestorPlace
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
Tickers BIIB DGX ESALY LH
Tags General RHHVF Briefs
From Benzinga
Tempest Therapeutics’ stock jumps 1,900% as liver-cancer treatment shows promise
Tickers RHHBY SPX TPST
Tags TPST SPX RHHBY
From MarketWatch
Tiziana Advances Phase 2 Site Selection For Its Lead Clinical Program In Non-Active Secondary Progressive Multiple Sclerosis (SPMS) And The Company Prepares For Six-Month Clinical Data Update
Tickers RHHBY SNY TLSA
Tags Market News Penny Stocks RHHBY
From Benzinga
Biotechnology Breakthroughs: 3 Biotech Stocks That Could Make Early Investors Rich
Tickers CRSP MRNA PSTX RHHBY
Tags MRNA PSTX RHHBY
From InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.